Breaking News
Get 50% Off 0
🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFF
CLAIM SALE
Close

Samsrita Labs Ltd (SAMM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
21.74 -0.44    -1.98%
18/08 - Closed. Currency in INR
Type:  Equity
Market:  India
ISIN:  INE579N01018 
S/N:  SAMSRITA
  • Volume: 471
  • Bid/Ask: 22.18 / 21.74
  • Day's Range: 21.74 - 21.74
Samsrita Labs 21.74 -0.44 -1.98%

Samsrita Labs Ltd Company Profile

 
Get an in-depth profile of Samsrita Labs Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

3

Equity Type

ORD

Samsrita Labs Limited operates as a biopharmaceutical company in India. The company offers DNA, RNA, and chromosomal-based tests for oncology, pharmacogenomics, infectious diseases, genetic disorders, transplantation typing, and prenatal and pre-implantation genetic diagnostics; and quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Sanger and Next Generation Sequencing (NGS), karyotype, and fluorescence in-situ hybridization analysis. It is also involved in the stem cell research and therapy, including regenerative medicine, bio-artificial organ scaffold development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology for the body organs of the liver, pancreas, neural, cardiac, vascular, renal, and orthopedic systems. In addition, company engages in new drug discovery, targeting therapeutic areas, such as Wilson's disease, non-alcoholic steatohepatitis, neuropathic pain, cardiovascular disease, cystinosis, and Huntington's disease. Further, it provides molecular prognosis and diagnostic services in the areas of cytogenetics, pharmacogenomics, pathology, radiology, hematology, biochemistry, microbiology, and others; and develops liver support devices, bioengineered implantable humanized nerve conduits, implantable nanochips carrying insulin-producing cells, and extracorporeal devices. Additionally, the company offers molecular diagnostics services to patients, private consultants, academic and hospital services, hospitals, and other healthcare institutions. Samsrita Labs Limited was formerly known as Dr. Habeebullah Life Sciences Limited and changed its name to Samsrita Labs Limited in October 2022. Samsrita Labs Limited was incorporated in 1996 and is based in Hyderabad, India.

Contact Information

Address 6-3-354/13/B2, Suryateja Apartments Flat.No.B2
Hindi Nagar Punjagutta Hyderabad, 500082
India
Phone -
Fax -

Top Executives

Name Age Since Title
Bommisetti Suryaprakasa Rao 57 2019 Independent Non-Executive Director
Kalidindi Krishnam Raju 66 2016 Compliance Officer, Executive Chairman & Whole Time Director
Konagalla Nagavenkata V. Narendra Kumar 48 2020 Whole-Time Director & CFO
Annapantula Vydehi 49 2023 Non-Executive Director
Srinivasa Rao Koyyalamudi 51 2025 Additional Independent Non Executive Director
Johnson Selva Raj 56 2025 Additional Independent Non Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SAMM Comments

Write your thoughts about Samsrita Labs Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email